Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer

Feng Jiao1, Ting Han1, Cuncun Yuan2

  • 11Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, 160 Pujian Road, Shanghai, 200127 China.

Cancer Cell International
|February 27, 2020
PubMed
Abstract

Insights

Bromodomain and extra-terminal domain (BET) protein BRD4 promotes pancreatic cancer growth and progression by upregulating caveolin-2. Targeting this interaction offers a potential therapeutic strategy for pancreatic cancer.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Bromodomain and extra-terminal domain (BET) proteins, particularly BRD4, are crucial for epigenetic regulation and cell survival.
  • BRD4 is a promising target for anticancer therapies.
  • Pancreatic cancer progression involves complex molecular mechanisms that require further elucidation.

Purpose of the Study:

  • To investigate the role of BRD4 in pancreatic cancer cell growth and progression.
  • To identify novel mechanisms underlying BRD4's function in pancreatic cancer.
  • To explore the potential of targeting BRD4 as a therapeutic strategy.

Main Methods:

  • Western blotting, immunohistochemistry, and real-time PCR were used to analyze BRD4 expression in patient tissues.
  • In vitro assays (colony formation, sulforhodamine B, Transwell) and in vivo studies in nude mice assessed BRD4's effects on cell proliferation, migration, and invasion.
  • RNA sequencing, ChIP, and dual luciferase reporter assays identified downstream targets and molecular mechanisms.

Main Results:

  • BRD4 was overexpressed in pancreatic cancer and promoted cell proliferation, migration, and invasion in vitro and in vivo.
  • Caveolin-2 was identified as a downstream target of BRD4, with BRD4 binding to its promoter region and upregulating its expression.
  • High expression of both BRD4 and caveolin-2 correlated with shorter patient survival, and both were identified as independent prognostic factors.

Conclusions:

  • BRD4 exhibits oncogenic effects in pancreatic cancer, partly through the upregulation of caveolin-2, enhancing cell growth.
  • The BRD4-caveolin-2 interaction represents a potential therapeutic target for pancreatic cancer.
  • Development of BET inhibitors targeting the BRD4-caveolin-2 interaction could be a viable treatment strategy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K